- Buyer
- Department of National Defence (DND)
- Deadline
- Due Nov 10
- Posted
- Sep 24, 2026
- Location
- *Foreign *Canada *Oceania *Africa *Unspecified *Remote Offsite *South America *Mexico *United States of America *World *Europe *Caribbean *North America *Central America *Asia *Aboriginal Lands · United States
- Category
- Public safety & defense
- Type
- Request for Proposal · Competitive - Open bidding
- Notice ID
- W6369-26-A033/B
- Source
- CanadaBuys Tender Notices
Description
NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 450 doses to be delivered before 31 March 2027. Optional requirements of 600 doses to be requested and delivered between 01 April 2027 and 31 March 2031. There are no security requirements associated with this requirement. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreem
What BidRover found in this bid
- Requirements extractedpending review
- Source documents readlisting only
- Fit score for your businessworkspace only
- Bid / no-bid briefworkspace only
Create a free account to save this search and get weekly alerts. Requirements, document reading, fit scores and team review are part of the paid workspace.
BidRover copies listing details from CanadaBuys Tender Notices. Always confirm requirements, amendments and submission instructions in the official notice before responding.